Indaptus Therapeutics, Inc.
INDP
$6.52
-$0.55-7.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 29.97% | 4.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.53% | 9.61% | |||
| Operating Income | 2.53% | -9.61% | |||
| Income Before Tax | -15.37% | -9.72% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -15.37% | -9.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.37% | -9.72% | |||
| EBIT | 2.53% | -9.61% | |||
| EBITDA | 2.53% | -9.61% | |||
| EPS Basic | -1.07% | 15.00% | |||
| Normalized Basic EPS | -1.07% | 15.00% | |||
| EPS Diluted | -1.07% | 15.00% | |||
| Normalized Diluted EPS | -1.07% | 15.00% | |||
| Average Basic Shares Outstanding | 14.14% | 29.09% | |||
| Average Diluted Shares Outstanding | 14.14% | 29.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||